Christopher Jewell - Jan 3, 2025 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role
Chief Scientific Officer
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Christopher Jewell
Stock symbol
RNAC
Transactions as of
Jan 3, 2025
Transactions value $
-$42,783
Form type
4
Date filed
1/7/2025, 08:05 PM
Previous filing
Jan 6, 2025
Next filing
Jan 13, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Sale -$21.1K -1.26K -2.26% $16.72 54.8K Jan 3, 2025 Direct F1
transaction RNAC Common Stock Sale -$21.6K -1.29K -2.35% $16.83 53.5K Jan 6, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.